Salvemos con ciencia

Equipo altruista independiente, comprometido con encontrar soluciones humanas y científicas a la crisis de salud originada por la pandemia COVID-19 en México.

[Salvemos con ciencia @SalvemosOrg]

Scientists develop breath test that rapidly detects COVID-19 virus – Washington University School of Medicine in St. Louis https://t.co/ByTehAuoUS

[Salvemos con ciencia @SalvemosOrg]

Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness - The Lancet Respiratory Medicine https://t.co/z0uAYKJCEk

[Salvemos con ciencia @SalvemosOrg]

Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations - The Lancet Respiratory Medicine https://t.co/CrCRsNWhXD

[Salvemos con ciencia @SalvemosOrg]

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants | npj Vaccines https://t.co/Du2t5uPq2T

[Salvemos con ciencia @SalvemosOrg]

The immunology of long COVID | Nature Reviews Immunology https://t.co/Rj4hpWYKIs

[Salvemos con ciencia @SalvemosOrg]

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study - The Lancet Infectious Diseases https://t.co/WdxMd5ZeMR

[Salvemos con ciencia @SalvemosOrg]

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy | Nature Communications https://t.co/AvzzJwxQpw

[Salvemos con ciencia @SalvemosOrg]

Intrinsic and effective severity of COVID-19 cases infected with the ancestral strain and Omicron BA.2 variant in Hong Kong | The Journal of Infectious Diseases | Oxford Academic https://t.co/IJLpZzngKW

[Salvemos con ciencia @SalvemosOrg]

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial - The Lancet Infectious Diseases https://t.co/L8awyJc3pe

[Salvemos con ciencia @SalvemosOrg]

The Origins of Covid-19 — Why It Matters (and Why It Doesn’t) | NEJM https://t.co/VyGV2d4uDh

[Salvemos con ciencia @SalvemosOrg]

SARS-CoV-2 airborne infection probability estimated by using indoor carbon dioxide | SpringerLink https://t.co/fPwe75UXjw

[Salvemos con ciencia @SalvemosOrg]

Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study - The Lancet Microbe https://t.co/znSJXITMUO

[Salvemos con ciencia @SalvemosOrg]

The therapeutic validation of long COVID - The Lancet Infectious Diseases https://t.co/XfURYXTcgb

[Salvemos con ciencia @SalvemosOrg]

US CDC announces indoor air guidance for COVID-19 after 3 years - The Lancet Respiratory Medicine https://t.co/bUH1INvEgd

[Salvemos con ciencia @SalvemosOrg]

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) https://t.co/CqDFaIMdU5

[Salvemos con ciencia @SalvemosOrg]

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection - Journal of Infection https://t.co/mNwlcJ679g

[Salvemos con ciencia @SalvemosOrg]

Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review | SpringerLink https://t.co/4jNAnvcZU0

[Salvemos con ciencia @SalvemosOrg]

🗣️ Importancia de la detección y el tratamiento temprano de COVID-19.

Conferencia impartida por el Dr. @FJEspinosa en el 9o LiveStream del equipo científico y médico de Salvemos con ciencia.

https://t.co/lOHJrV6rvL a través de @YouTube

[Salvemos con ciencia @SalvemosOrg]

SARS-CoV-2 transmission with and without mask wearing or air cleaners in schools in Switzerland: A modeling study of epidemiological, environmental, and molecular data | PLOS Medicine https://t.co/mKimCz3Ei8

[Salvemos con ciencia @SalvemosOrg]

COVID-19 has left the world less prepared for an influenza pandemic | Nature Medicine. https://t.co/CWd5Paagsv